These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
240 related items for PubMed ID: 22033230
1. Emergence of vancomycin-resistant Staphylococcus aureus identified in the Tlemcen university hospital (North-West Algeria). Rebiahi SA, Abdelouahid DE, Rahmoun M, Abdelali S, Azzaoui H. Med Mal Infect; 2011 Dec; 41(12):646-51. PubMed ID: 22033230 [Abstract] [Full Text] [Related]
2. [Antibiotic susceptibility of Staphylococcus aureus strains isolated in two university hospitals in Rabat, Morocco]. Elhamzaoui S, Benouda A, Allali F, Abouqual R, Elouennass M. Med Mal Infect; 2009 Dec; 39(12):891-5. PubMed ID: 19269758 [Abstract] [Full Text] [Related]
3. [Investigation of reduced vancomycin susceptibility in methicillin-resistant staphylococci]. Kuşcu F, Oztürk DB, Gürbüz Y, Tütüncü EE, Sencan I, Gül S. Mikrobiyol Bul; 2011 Apr; 45(2):248-57. PubMed ID: 21644067 [Abstract] [Full Text] [Related]
8. Growing Resistance to Vancomycin among Methicillin Resistant Staphylococcus Aureus Isolates from Different Clinical Samples. Pahadi PC, Shrestha UT, Adhikari N, Shah PK, Amatya R. JNMA J Nepal Med Assoc; 2014 Apr; 52(196):977-81. PubMed ID: 26982895 [Abstract] [Full Text] [Related]
9. Methicillin-resistant Staphylococcus aureus with reduced susceptibility to vancomycin in Sanprasitthiprasong Hospital. Panomket P, Thirat S, Wanram S, Sranujit RP. J Med Assoc Thai; 2014 Apr; 97 Suppl 4():S7-11. PubMed ID: 24851558 [Abstract] [Full Text] [Related]
10. Incidence and characteristics of vancomycin nonsusceptible strains of methicillin-resistant Staphylococcus aureus at Hershey Medical Center. Kosowska-Shick K, Ednie LM, McGhee P, Smith K, Todd CD, Wehler A, Appelbaum PC. Antimicrob Agents Chemother; 2008 Dec; 52(12):4510-3. PubMed ID: 18838583 [Abstract] [Full Text] [Related]
11. Rising incidence of Staphylococcus aureus with reduced susceptibility to vancomycin and susceptibility to antibiotics: a global analysis 2004-2009. Hawser SP, Bouchillon SK, Hoban DJ, Dowzicky M, Babinchak T. Int J Antimicrob Agents; 2011 Mar; 37(3):219-24. PubMed ID: 21239146 [Abstract] [Full Text] [Related]
12. Glycopeptide and daptomycin susceptibility and vancomycin heteroresistance of methicillin-resistant Staphylococcus aureus (MRSA) clinical isolates from a Greek university hospital. Panagea T, Galani I, Souli M, Karantani I, Giamarellou H, Petrikkos G. Int J Antimicrob Agents; 2011 Nov; 38(5):451-2. PubMed ID: 21840688 [No Abstract] [Full Text] [Related]
15. Ceftaroline pharmacodynamic activity versus community-associated and healthcare-associated methicillin-resistant Staphylococcus aureus, heteroresistant vancomycin-intermediate S. aureus, vancomycin-intermediate S. aureus and vancomycin-resistant S. aureus using an in vitro model. Zhanel GG, Rossnagel E, Nichol K, Cox L, Karlowsky JA, Zelenitsky S, Noreddin AM, Hoban DJ. J Antimicrob Chemother; 2011 Jun; 66(6):1301-5. PubMed ID: 21429940 [Abstract] [Full Text] [Related]
16. Evaluation of dalbavancin, tigecycline, minocycline, tetracycline, teicoplanin and vancomycin against community-associated and multidrug-resistant hospital-associated meticillin-resistant Staphylococcus aureus. Huang V, Cheung CM, Kaatz GW, Rybak MJ. Int J Antimicrob Agents; 2010 Jan; 35(1):25-9. PubMed ID: 19900792 [Abstract] [Full Text] [Related]
17. MRSA--too many hurdles to overcome: a study from Central India. Mallick SK, Basak S. Trop Doct; 2010 Apr; 40(2):108-10. PubMed ID: 20305109 [Abstract] [Full Text] [Related]